CRISPR Therapeutics AG
| CIK |
Ticker |
Name |
Accession Number |
Date |
Form |
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-25-054711 |
2025-04-16 16:05:18 |
DEF 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-25-050391 |
2025-04-03 16:10:44 |
PRE 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-043025 |
2024-04-09 16:42:47 |
DEF 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-037243 |
2024-03-27 16:30:39 |
PRE 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-014831 |
2023-04-26 16:21:07 |
DEF 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-012305 |
2023-04-10 16:40:31 |
PRE 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-22-006098 |
2022-04-25 16:23:20 |
DEF 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-22-005617 |
2022-04-12 16:28:38 |
PRE 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001564590-21-021355 |
2021-04-28 16:14:25 |
DEF 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001564590-21-017625 |
2021-04-05 16:18:47 |
PRE 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001564590-20-018495 |
2020-04-24 16:09:49 |
DEF 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001564590-20-014570 |
2020-03-31 17:00:37 |
PRE 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001193125-19-129267 |
2019-04-30 16:05:35 |
DEF 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001193125-19-101691 |
2019-04-09 16:15:51 |
PRE 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001193125-18-121109 |
2018-04-18 16:44:56 |
DEF 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001193125-18-105044 |
2018-04-02 17:28:42 |
PRE 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001193125-17-127264 |
2017-04-18 15:19:58 |
DEF 14A
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001193125-17-110109 |
2017-04-04 16:02:58 |
PRE 14A
|
